Ads
related to: optimer careersLarge Employment Site (>10 Million Unique Visitors Per Month) - TAtech
everyjobforme.com has been visited by 100K+ users in the past month
jobhat.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Optimer Pharmaceuticals Inc ( Nasdaq : OPTR) was a biopharmaceutical company, originally headquartered in San Diego, California, and later moved to Jersey City, New Jersey, United States. The company focused on developing specialty drugs to treat gastrointestinal infections and related diseases. In 2011, it received regulatory approval for the ...
Optimer ligands are short synthetic oligonucleotide molecules composed of DNA or RNA that bind to a specific target molecule. They are engineered to bind their target molecules with affinity typically in the low nanomolar range. [1] Optimers can be used as antibody mimetics in a range of applications, [2] [3] [4] and have been optimized to ...
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Optimer Pharmaceuticals has ...
Optimer Pharmaceuticals (NAS: OPTR) is expected to report Q4 earnings on Feb. 28. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year ...
In October, Optimer announced a 25% price cut on Dificid to help boost its adoption rate, and it looks like hospitals are indeed biting. Now what: Expect the positive sales momentum to continue.
A typical aptamer is a synthetically generated ligand exploiting the combinatorial diversity of DNA, RNA, XNA, or peptide to achieve strong, specific binding for a particular target molecule or family of target molecules. Aptamers are occasionally classified as "chemical antibodies" or "antibody mimics". [9]